ABOUT TAYLOR BRIGHT, PhD
A. Taylor Bright, PhD, is a serial biomedical entrepreneur with a passion to drive new technologies out of the research lab and into the clinic where they can have the most impact. Dr Bright co-founded Novoron Bioscience, Inc., a biotechnology startup located in San Diego, CA, in 2013 and has helped raise $2.5 MM in NIH grant-funding to support Novoron’s cutting-edge therapeutic molecule capable of regenerating damaged neurons in spinal cord injury and multiple sclerosis.
Additionally, Dr. Bright co-founded TEC Biosciences Inc., a biotechnology startup located in Lexington, KY, in an effort to bring a novel metabolomics testing platform into the clinic for use in diagnosing chronic diseases such as autism and post traumatic stress disorder. Dr. Bright successfully led TECbio’s seed funding round in 2017 and has overseen the launch of three product lines conducting high-complexity tests for customers in the academic research, clinical, and hemp industries.
Dr. Bright holds a PhD from the University of California, San Diego (2013) and an AB from Princeton University (2005).